ER&D companies are expected to show modest growth in Q4FY26, as demand stabilizes but recovery is delayed. Among them, KPIT is favored for its projected 1.6% increase, while Tata Elxsi and Cyient anticipate smaller gains. Improved margins could come from currency depreciation and cost control measures. Analysts recommend buying shares of KPIT, Cyient, and LTTS, but advise reducing holdings in Tata Elxsi.

Cyient has announced a new CFO appointment effective from April 2026, with Shrinivas Kulkarni taking on the role. Current CFO Prabhakar Atla will be transitioning to the COO position, bringing his extensive expertise to both roles alongside Kulkarni.